59 assets in HIV Infectious Disease

Therapeutic assets addressing HIV Infectious Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dolutegravir HIV Infectious Disease	Instituto Mexicano del Seguro Social	P4	BBB (76)
Doravirine HIV Infectious Disease	José Antonio Mata Marín	P4	BBB (74)
Lamivudine HIV Infectious Disease	José Antonio Mata Marín	P4	BBB (74)
Adriamycin HIV Infectious Disease	UNC Lineberger Comprehensive Cancer Center	P4	BBB (73)
Etoposide HIV Infectious Disease	AIDS Malignancy Consortium	P2	BBB (73)
Bictegravir HIV Infectious Disease	José Antonio Mata Marín	P4	BBB (72)
Rosuvastatin HIV Infectious Disease	Kirby Institute	P4	BBB (72)
(±)-Ftc HIV Infectious Disease	José Antonio Mata Marín	P4	BB (71)
Tenofovir Alafenamide HIV Infectious Disease	José Antonio Mata Marín	P4	BB (71)
Cyclophosphamide HIV Infectious Disease	AIDS Malignancy Consortium	P3	BB (70)
Metformin HIV Infectious Disease	Brigham and Women's Hospital	P4	BB (70)
Prednisone HIV Infectious Disease	City of Hope Medical Center	P2	BB (70)
Tenofovir Disoproxil Fumarate HIV Infectious Disease	José Antonio Mata Marín	P4	BB (70)
Vincristine Sulfate HIV Infectious Disease	City of Hope Medical Center	P3	BB (70)
Nivestim HIV Infectious Disease	Fred Hutchinson Cancer Center	P3	BB (69)
Camustine HIV Infectious Disease	Fred Hutchinson Cancer Center	P2	BB (68)
Cytarabine HIV Infectious Disease	AIDS Malignancy Consortium	P3	BB (68)
Rituximab HIV Infectious Disease	City of Hope Medical Center	P2	BB (68)
Ezetimibe HIV Infectious Disease	Kirby Institute	P4	BB (67)
Melphalan HIV Infectious Disease	AIDS Malignancy Consortium	P2	BB (67)
Fluorouracilum HIV Infectious Disease	National Cancer Institute (NCI)	P3	BB (66)
Fluoxetine HIV Infectious Disease	University of Ibadan	P4	BB (65)
Liraglutide HIV Infectious Disease	Brigham and Women's Hospital	P4	BB (65)
Naltrexone HIV Infectious Disease	Emory University	P4	BB (65)
Rilpivirine HIV Infectious Disease	Fundacion SEIMC-GESIDA	P4	BB (65)
Busulfanum HIV Infectious Disease	City of Hope Medical Center	P2	B (63)
Biktarvy HIV Infectious Disease	East Carolina University	P4	B (62)
Fludarabine HIV Infectious Disease	AIDS Malignancy Consortium	P2	B (62)
Nivolumab HIV Infectious Disease	Universita di Verona	P2	B (62)
Sfx-01 (Sulforaphane Stabilized With .Alpha. Cyclodextrin) HIV Infectious Disease	Sunshine Specialty Health Care	P4	B (62)
Symtuza HIV Infectious Disease	East Carolina University	P4	B (62)
Moderna Bivalent Mrna Vaccine HIV Infectious Disease	Monash University	P3	B (60)
Pfizer Bivalent Covid-19 Vaccine HIV Infectious Disease	Monash University	P3	B (60)
Ipilimumab HIV Infectious Disease	Universita di Verona	P2	B (59)
Dapagliflozin HIV Infectious Disease	Kirby Institute	P3	B (57)
Elranatamab HIV Infectious Disease	University of Illinois at Chicago	P2/3	B (57)
Pitavastatin HIV Infectious Disease	Kirby Institute	P3	B (57)
Semaglutide HIV Infectious Disease	National Institute of Allergy and Infectious Diseases (NIAID)	P2	B (57)
17.BETA.-(1-KETOETHYL)-.DELTA. SUP(5)-ANDROSTEN-3.BETA.-OL HIV Infectious Disease	Massachusetts General Hospital	P2	CCC (53)
Bempedoic Acid HIV Infectious Disease	Priscilla Hsue, MD	P2	CCC (53)
Capecitabine HIV Infectious Disease	National Cancer Institute (NCI)	P2	CCC (53)
Empagliflozin HIV Infectious Disease	Abdelrahman Mahmoud	P2	CCC (53)
Escitalopram HIV Infectious Disease	National Institute of Allergy and Infectious Diseases (NIAID)	P2	CCC (53)
Fludeoxyglucose HIV Infectious Disease	National Cancer Institute (NCI)	P2	CCC (53)
Muamycin HIV Infectious Disease	National Cancer Institute (NCI)	P2	CCC (53)
pds0101 HIV Infectious Disease	Weill Medical College of Cornell University	P2	CCC (53)
Pramipexole HIV Infectious Disease	National Institute of Allergy and Infectious Diseases (NIAID)	P2	CCC (53)
Resmetirom HIV Infectious Disease	Naga P. Chalasani	P2	CCC (53)
Thiotepa HIV Infectious Disease	Fred Hutchinson Cancer Center	P2	CCC (53)
Vitamin B-1 HIV Infectious Disease	Liverpool School of Tropical Medicine	P2	CCC (53)

Showing 1 to 50 of 59 assets

PreviousPage 1 of 2Next